Evolution of BDNF serum levels during the first six months after alcohol withdrawal

References

• Ansseau M, Besson J, Lejoyeux M, Pinto E, Landry U, Cornes M, Deckers F, Potgieter A, Ades J. 2000. A French translation of the obsessive-compulsive drinking scale for craving in alcohol-dependent patients: a validation study in Belgium, France, and Switzerland. Eur Addict Res. 6:51–56.
   PubMed Web of Science ®Google Scholar
• Cervantes EA, Miller WR, Tonigan JS. 1994. Comparison of timeline follow-back and averaging methods for quantifying alcohol consumption in treatment research. Assessment. 1:23–30.
   PubMedGoogle Scholar
• Chen JJ, Wang T, An CD, Jiang CY, Zhao J, Li S. 2016. Brain-derived neurotrophic factor: a mediator of inflammation-associated neurogenesis in Alzheimer's disease. Rev Neurosci. 27:793–811.
   PubMed Web of Science ®Google Scholar
• Chen SD, Wu CL, Hwang WC, Yang DI. 2017. More insight into BDNF against neurodegeneration: anti-apoptosis, anti-oxidation, and suppression of autophagy. Int J Mol Sci. 18:E545.
   PubMed Web of Science ®Google Scholar
• Costa MA, Girard M, Dalmay F, Malauzat D. 2011. Brain-derived neurotrophic factor serum levels in alcohol-dependent subjects 6 months after alcohol withdrawal. Alcohol Clin Exp Res. 35:1966–1973.
   PubMed Web of Science ®Google Scholar
• Crews FT, Buckley T, Dodd PR, Ende G, Foley N, Harper C, He J, Innes D, Loh EW, Pfefferbaum A, et al. 2005. Alcoholic neurobiology: changes in dependence and recovery. Alcohol Clin Exp Res. 29:1504–1513.
   PubMed Web of Science ®Google Scholar
• Crews FT, Nixon K, Wilkie ME. 2004. Exercise reverses ethanol inhibition of neural stem cell proliferation. Alcohol. 33:63–71.
   PubMed Web of Science ®Google Scholar
• de la Monte SM, Longato L, Tong M, DeNucci S, Wands JR. 2009. The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids. Int J Environ Res Public Health. 6:2055–2075.
   PubMed Web of Science ®Google Scholar
• Eyileten C, Kaplon-Cieslicka A, Mirowska-Guzel D, Malek L, Postula M. 2017. Antidiabetic Effect of Brain-Derived Neurotrophic Factor and Its Association with Inflammation in Type 2 Diabetes Mellitus. J Diabetes Res. 2017:1–14.
   Web of Science ®Google Scholar
• Gache P, Michaud P, Landry U, Accietto C, Arfaoui S, Wenger O, Daeppen JB. 2005. The Alcohol Use Disorders Identification test (AUDIT) as a screening tool for excessive drinking in primary care: reliability and validity of a French version. Alcohol Clin Exp Res. 29:2001–2007.
   PubMed Web of Science ®Google Scholar
• García-Marchena N, Silva-Peña D, Martín-Velasco AI, Villanúa MÁ, Araos P, Pedraz M, Maza-Quiroga R, Romero-Sanchiz P, Rubio G, Castilla-Ortega E, et al. 2017. Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders. PLoS One. 12:e0187634.
   PubMed Web of Science ®Google Scholar
• Geisel O, Hellweg R, Müller CA. 2016. Serum levels of brain-derived neurotrophic factor in alcohol-dependent patients receiving high-dose baclofen. Psychiatry Res. 240:177–180.
   PubMed Web of Science ®Google Scholar
• Genzer Y, Chapnik N, Froy O. 2017. Effect of brain-derived neurotrophic factor (BDNF) on hepatocyte metabolism. Int J Biochem Cell Biol. 88:69–74.
   PubMed Web of Science ®Google Scholar
• Girard M, Malauzat D, Nubukpo P. 2017. Serum inflammatory molecules and markers of neuronal damage in alcohol-dependent subjects after withdrawal. World J Biol Psychiatry. 31:1–15.
   Google Scholar
• Grant KA, Tonigan JS, Miller WR. 1995. Comparison of three alcohol consumption measures: a concurrent validity study. J Stud Alcohol. 56:168–172.
   PubMed Web of Science ®Google Scholar
• Hamilton M. 1959. The assessment of anxiety states by rating. Br J Med Psychol. 32:50–55.
   PubMed Web of Science ®Google Scholar
• Hamilton M. 1969. Diagnosis and rating of anxiety. In: Lader MH, editor. Studies of anxiety. Brit J Psychiatry, Spec Pub. 3:76–79.
   Google Scholar
• Han C, Bae H, Won SD, Roh S, Kim DJ. 2015. The relationship between brain-derived neurotrophic factor and cognitive functions in alcohol-dependent patients: a preliminary study. Ann Gen Psychiatry. 14:30.
   PubMed Web of Science ®Google Scholar
• Harper C. 1998. The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain? J Neuropathol Exp Neurol. 57:101–110.
   PubMed Web of Science ®Google Scholar
• Heberlein A, Lenz B, Opfermann B, Gröschl M, Janke E, Stange K, Groh A, Kornhuber J, Frieling H, Bleich S, et al. 2016. Association of testosterone and BDNF serum levels with craving during alcohol withdrawal. Alcohol. 54:67–72.
   PubMed Web of Science ®Google Scholar
• Heberlein A, Muschler M, Wilhelm J, Frieling H, Lenz B, Gröschl M, Kornhuber J, Bleich S, Hillemacher T. 2010. BDNF and GDNF serum levels in alcohol-dependent patients during withdrawal. Prog Neuropsychopharmacol Biol Psychiatry. 34:1060–1064.
   PubMed Web of Science ®Google Scholar
• Hoeppner BB, Stout RL, Jackson KM, Barnett NP. 2010. How good is fine-grained Timeline Follow-back data? Comparing 30-day TLFB and repeated 7-day TLFB alcohol consumption reports on the person and daily level. Addict Behav. 35:1138–1143.
   PubMed Web of Science ®Google Scholar
• Huang MC, Chen CH, Chen CH, Liu SC, Ho CJ, Shen WW, Leu SJ. 2008. Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal. Alcohol Alcohol. 43:241–245.
   PubMed Web of Science ®Google Scholar
• Huang MC, Chen CH, Liu HC, Chen CC, Ho CC, Leu SJ. 2011. Differential patterns of serum brain-derived neurotrophic factor levels in alcoholic patients with and without delirium tremens during acute withdrawal. Alcohol Clin Exp Res. 35:126–131.
   PubMed Web of Science ®Google Scholar
• Jatlow P. O’Malley Ss 2010. Clinical (nonforensic) application of ethyl glucuronide measurement: are we ready? Alcohol Clin Exp Res. 34:868–875.
   Web of Science ®Google Scholar
• Jeanblanc J, He DY, Carnicella S, Kharazia V, Janak PH, Ron D. 2009. Endogenous BDNF in the dorsolateral striatum gates alcohol drinking. J Neurosci. 29:13494–13502.
   PubMed Web of Science ®Google Scholar
• Joe KH, Kim YK, Kim TS, Roh SW, Choi SW, Kim YB, Lee HJ, Kim DJ. 2007. Decreased plasma brain-derived neurotrophic factor levels in patients with alcohol dependence. Alcoholism Clin Exp Res. 31:1833–1838.
   PubMed Web of Science ®Google Scholar
• Kalivas P W, O'Brien C. 2008. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacol. 33:166–141.
   PubMed Web of Science ®Google Scholar
• Koskela M, Bäck S, Võikar V, Richie CT, Domanskyi A, Harvey BK, Airavaara M. 2017. Update of neurotrophic factors in neurobiology of addiction and future directions. Neurobiol Dis. 97:189–200.
   PubMed Web of Science ®Google Scholar
• Lee BC, Choi IG, Kim YK, Ham BJ, Yang BH, Roh S, Choi J, Lee JS, Oh DY, Chai YG. 2009. Relation between plasma brain-derived neurotrophic factor and nerve growth factor in the male patients with alcohol dependence. Alcohol. 43:265–269.
   PubMed Web of Science ®Google Scholar
• Lemperière T, Lépine JP, Rouillon F, Hardy P, Ades J, Luaute JP, Ferrand I. 1984. Comparaison de différents instruments d’évaluation de la dépression à l’occasion d’une étude sur l’Athymil 30 mg. Ann Med Psychol (Paris). 142:1206–1212.
   PubMed Web of Science ®Google Scholar
• Logrip ML, Janak PH, Ron D. 2008. Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake. FASEB J. 22:2393–2404.
   PubMed Web of Science ®Google Scholar
• Logrip ML, Janak PH, Ron D. 2009. Escalating ethanol intake is associated with altered corticostriatal BDNF expression. J Neurochem. 109:1459–1468.
   PubMed Web of Science ®Google Scholar
• McLung CA, Nestler EJ. 2008. Neuroplasticity mediated by altered gene expression. Neuropsychopharmacol Rev. 33:3–17.
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Asberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry. 134:382–389.
   PubMed Web of Science ®Google Scholar
• Moonat S, Starkman BG, Sakharkar A, Pandey SC. 2010. Neuroscience of alcoholism: molecular and cellular mechanisms. Cell Mol Life Sci. 67:73–88.
   PubMed Web of Science ®Google Scholar
• Musshoff F, Albermann E, Madea B. 2010. Ethyl glucuronide and ethyl sulfate in urine after consumption of various beverages and foods-misleading results? Int J Legal Med. 124:623–630.
   PubMed Web of Science ®Google Scholar
• Naassila M. 2018. Neurobiological bases of alcohol addiction. Presse Med. 47:554–564.
   PubMed Web of Science ®Google Scholar
• Neupane SP, Lien L, Ueland T, Mollnes TE, Aukrust P, Bramness JG. 2015. Serum brain-derived neurotrophic factor levels in relation to comorbid depression and cytokine levels in Nepalese men with alcohol-use disorders. Alcohol. 49:471–478.
   PubMed Web of Science ®Google Scholar
• Nixon K, Crews FT. 2004. Temporally specific burst in cell proliferation increases hippocampal neurogenesis in protracted abstinence from alcohol. J Neurosci. 24:9714–9722.
   PubMed Web of Science ®Google Scholar
• Nixon K, Kim DH, Potts EN, He J, Crews ET. 2008. Distinct cell proliferation events during abstinence after alcohol dependence: microglia proliferation precedes neurogenesis. Neurobiol Dis. 31:218–229.
   PubMed Web of Science ®Google Scholar
• Noren Hooten N, Ejiogu N, Zonderman AB, Evans MK. 2015. Protective effects of BDNF against C-reactive protein-induced inflammation in women. Mediators Inflamm. 2015:1–9.
   Web of Science ®Google Scholar
• Nubukpo P, Ramoz N, Girard M, Malauzat D, Gorwood P. 2017. Determinants of blood brain-derived neurotrophic factor blood levels in patients with alcohol use disorder. Alcohol Clin Exp Res. 41:1280–1287.
   PubMed Web of Science ®Google Scholar
• Ornell F, Hansen F, Schuch F.B, Pezzini Rebelatto F, Tavares A.L, Scherer J.N, Valerio A.G, Pechansky F, Paim Kessler F.H, von Diemen L. 2018. Brain-derived neurotrophic factor in substance use disorders: A systematic review and meta-analysis. Drug Alcohol Depend. 193:91–103.
   PubMed Web of Science ®Google Scholar
• Pandey SC, Zhang H, Roy A, Misra K. 2006. Central and medial amygdaloid brain-derived neurotrophic factor signaling plays a critical role in alcohol-drinking and anxiety-like behaviors. J Neurosci. 26:8320–8331.
   PubMed Web of Science ®Google Scholar
• Papathanassoglou ED, Miltiadous P, Karanikola MN. 2015. May BDNF be implicated in the exercise-mediated regulation of inflammation? critical review and synthesis of evidence. Biol Res Nurs. 17:521–539.
   PubMed Web of Science ®Google Scholar
• Pellet J. 1993. L’échelle d’anxiété de Hamilton. In: L ‘évaluation clinique standardisée en psychiatrie. Editions Médicales Pierre Fabre. Paris: Tome 1; p. 297–302.
   Google Scholar
• Pichot P, Pull CB, von Frenckell R, Pull MC. 1981. Une analyse factorielle de l’échelle d’appréciation de l’anxiété de Hamilton. Psychiat Fennica Int Ed. 1981:183–189.
   Google Scholar
• Reynolds PM, Mueller SW, MacLaren R. 2015. A comparison of dexmedetomidine and placebo on the plasma concentrations of NGF, BDNF, GDNF, and epinephrine during severe alcohol withdrawal. Alcohol. 49:15–19.
   PubMed Web of Science ®Google Scholar
• Ron D, Berger A. 2018. Targeting the intracellular signaling “STOP” and “GO” pathways for the treatment of alcohol use disorders. Psychopharmacology (Berl). 235:1727–1743.
   PubMed Web of Science ®Google Scholar
• Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. 1993. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative project on early detection persons with harmful alcohol consumption. Addiction. 88:791–804.
   PubMed Web of Science ®Google Scholar
• Searles JS, Helzer JE, Walter DE. 2000. Comparison of drinking patterns measured by daily reports and timeline follow back. Psychol Addict Behav. 14:277–286.
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psy. 59:22–33.
   Web of Science ®Google Scholar
• Spanagel R. 2009. Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol Rev. 89:649–705.
   PubMed Web of Science ®Google Scholar
• Sullivan EV, Rosenbloom MJ, Pfefferbaum A. 2000. Pattern of motor and cognitive deficits in detoxified alcoholic men. Alcoholism Clin Exp Res. 24:611–621.
   PubMed Web of Science ®Google Scholar
• Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, for the STROBE Initiative 2007. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 147:573–577.
   PubMed Web of Science ®Google Scholar
• Ward RJ, Lallemand F, de Witte P. 2009. Biochemical and neurotransmitter changes implicated in alcohol-induced brain damage in chronic or ‘binge drinking’ alcohol abuse. Alcohol. 44:128–135.
   Web of Science ®Google Scholar
• Wurzelmann M, Romeika J, Sun D. 2017. Therapeutic potential of brain-derived neurotrophic factor (BDNF) and a small molecular mimics of BDNF for traumatic brain injury. Neural Regen Res. 12:7–12.
   PubMed Web of Science ®Google Scholar
• Yang B, Ren Q, Zhang JC, Chen QX, Hashimoto K. 2017. Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain-liver axis. Transl Psychiatry. 7:e1128
   PubMed Web of Science ®Google Scholar
• Zanardini R, Fontana A, Pagano R, Mazzaro E, Bergamasco F, Romagnosi G, Gennarelli M, Bocchio-Chiavetto L. 2011. Alterations of brain derived neurotrophic factor serum levels in patients with alcohol dependence. Alcohol Clin Exp Res. 35:1529–1533.
   PubMed Web of Science ®Google Scholar
• Zhang JC, Yao W, Hashimoto K. 2016a. Brain-derived neurotrophic factor (BDNF)-TrkB signaling in inflammation-related depression and potential therapeutic targets. Curr Neuropharmacol. 14:721–731.
   PubMed Web of Science ®Google Scholar
• Zhang XY, Tan YL, Chen DC, Tan SP, Yang FD, Zunta-Soares GB, Soares JC. 2016b. Effects of cigarette smoking and alcohol use on neurocognition and BDNF levels in a Chinese population. Psychopharmacology (Berl). 233:435–445.
   PubMed Web of Science ®Google Scholar
• Zhou L, Xiong J, Ruan CS, Ruan Y, Liu D, Bao JJ, Zhou XF. 2018. ProBDNF/p75NTR/sortilin pathway is activated in peripheral blood of patients with alcohol dependence. Transl Psychiatry. 7:2.
   PubMed Web of Science ®Google Scholar